ALAYA.BIO
LIVE

Serial Number

79408189

Owner

Alaya.bio

Attorney

Boris Umansky

Filing Date

Jul 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ALAYA.BIO Trademark

Serial Number: 79408189

ALAYA.BIO is a trademark filed by Alaya.bio on July 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Alaya.bio

15 rue des Halles

Entity Type: 34

Trademark Details

Filing Date

July 26, 2024

Registration Date

Not Registered

Goods & Services

Biotechnology-derived products and preparations applied to the medical field, namely, gene and cell therapy products and preparations for medical purposes; gene and cell therapy products and preparations, namely, cells targeting polymeric nanoparticle based on vector payloads for medical purposes; medical products, substances and preparations, namely, biotechnology-derived products and preparations being cell targeting preparations and products in the nature of polymeric nanoparticle based on vector payloads and pharmaceutical products for immunotherapy and cancer treatment, autoimmune diseases, genetic diseases, diseases affecting the central nervous system; none of the aforementioned goods relating to or being in the nature of nutritional supplements

Medical research; pharmacological research being pharmaceutical research services; research and development in the field of biotechnology; biotechnology advice, namely, consulting services in the field of biotechnology and cell and gene therapy; preparation of reports in the field of biotechnology for scientific research purposes; information about scientific research in the field of biochemistry and biotechnology; scientific research in the fields of cell therapy and gene therapy; scientific research in the fields of in-vivo gene therapy and cell therapy; medical and scientific research in the field of immunotherapy; medical and scientific research in the field of oncology; medical and scientific research in the field of autoimmune disease; medical and scientific research in the field of genetic disease; medical and scientific research in the field of diseases affecting the central nervous system

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 11, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 11, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 11, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 19, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 31, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 26, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 25, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 3, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 1, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2024 REPR